
Intranasal administration of TAT-haFGF14-154 attenuates disease progression in a mouse model of Alzheimer's disease
Keywords: ACh; acetylcholine; AChE; acetylcholinesterase; AD; Alzheimer's disease; Aβ1-42; β-amyloid protein1-42; BBB; blood-brain barrier; BCA; bicinchoninic acid; ChAT; choline acetyltransferase; ELISA; enzyme-linked immunosorbent assay; GSH-Px; glutath